This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Infectious Disease Control and Prevention Act (South Korea) | |
|---|---|
| Name | Infectious Disease Control and Prevention Act |
| Legislature | National Assembly (South Korea) |
| Enacted by | President of South Korea |
| Date enacted | 2015 |
| Territorial extent | South Korea |
| Status | in force |
Infectious Disease Control and Prevention Act (South Korea) The Infectious Disease Control and Prevention Act is a statutory framework enacted by the National Assembly (South Korea) and promulgated by the President of South Korea to organize responses to communicable threats in South Korea. The Act integrates statutory tools used during crises such as the Middle East respiratory syndrome outbreak in South Korea (2015) and the COVID-19 pandemic in South Korea, and aligns administrative practice across agencies including the Ministry of Health and Welfare (South Korea), the Korea Disease Control and Prevention Agency, and the Seoul Metropolitan Government. It has been subject to scrutiny from legal scholars at institutions like Seoul National University and policy analysts at Korea University.
The Act traces antecedents to public health statutes debated in the National Assembly (South Korea) after incidents such as the Middle East respiratory syndrome outbreak in South Korea (2015), prompting revisions influenced by recommendations from the World Health Organization and comparative law studies referencing the Public Health (Control of Disease) Act, the Quarantine Act (Japan), and the Communicable Disease Control Law (United Kingdom). Major amendments were enacted following executive proposals from the Ministry of Health and Welfare (South Korea), legislative deliberation in committees chaired by members of the Democratic Party of Korea and the People Power Party (South Korea), and judicial review by the Constitutional Court of Korea addressing civil liberties and administrative authority. The iterative legislative history reflects interactions with the Korea Disease Control and Prevention Agency and local governments including the Busan Metropolitan City and Gyeonggi Province.
The Act creates a taxonomy of communicable conditions modeled on classifications used by the World Health Organization and criteria applied by the Centers for Disease Control and Prevention (United States), dividing diseases into categories that determine reporting and control measures. Definitions reference pathogens identified by agencies such as the Korea Disease Control and Prevention Agency, clinical syndromes treated at Seoul National University Hospital and Asan Medical Center, and international reporting obligations under the International Health Regulations (2005). Classification affects statutory lists that have included agents like coronaviruses associated with the COVID-19 pandemic in South Korea and Middle East respiratory syndrome outbreak in South Korea (2015), and influences intersections with laws administered by the Ministry of Food and Drug Safety and the Korean Centers for Disease Control and Prevention (former).
The statute authorizes measures including mandatory reporting by clinicians at institutions such as Yonsei University Health System, isolation and quarantine implemented by municipal authorities like the Seoul Metropolitan Government, and use of diagnostic resources allocated by the Ministry of Science and ICT and the Korea Centers for Disease Control and Prevention. It prescribes notification protocols for healthcare facilities including Samsung Medical Center and regulatory oversight of infection control in congregate settings such as facilities overseen by the Ministry of Gender Equality and Family and long-term care institutions inspected by the Ministry of Health and Welfare (South Korea). The Act also enables distribution of medical countermeasures procured under procurement frameworks used by the Public Procurement Service (South Korea) and logistical support coordinated with the Ministry of Interior and Safety.
The law delineates roles for central agencies including the Ministry of Health and Welfare (South Korea), the Korea Disease Control and Prevention Agency, and the Ministry of Interior and Safety, while assigning operational duties to provincial entities such as the Gyeonggi Provincial Government and municipal governments like the Daegu Metropolitan City. It prescribes coordination mechanisms with research institutions such as the Korea Advanced Institute of Science and Technology and public hospitals like Incheon St. Mary’s Hospital, and specifies channels for interagency cooperation with the Ministry of Foreign Affairs for international notification and the Ministry of Employment and Labor (South Korea) for workplace-related interventions. Parliamentary oversight occurs through committees of the National Assembly (South Korea).
Mandatory surveillance and reporting obligations place duties on clinicians at facilities such as Seoul National University Hospital and laboratories accredited by the Korean Society for Laboratory Medicine, requiring notification to the Korea Disease Control and Prevention Agency. The statute permits use of digital tools including contact tracing applications deployed in coordination with telecommunications firms regulated under the Ministry of Science and ICT, while intersecting with privacy protections considered by the Personal Information Protection Commission (South Korea) and judicial standards set by the Constitutional Court of Korea. Data-sharing protocols have been debated with stakeholders including civil society groups affiliated with National Human Rights Commission of Korea and academic centers at Korea University.
The Act grants emergency powers to declare public health crises, enabling mobilization of resources from agencies such as the Ministry of National Defense (South Korea) and logistical support from the Ministry of Land, Infrastructure and Transport (South Korea), and authorizes temporary measures executed by metropolitan governments like Busan Metropolitan City. These powers were invoked during events such as the COVID-19 pandemic in South Korea and guided operational responses by the Korea Disease Control and Prevention Agency in partnership with hospitals including Asan Medical Center. Emergency measures are constrained by judicial review from the Constitutional Court of Korea and legislative oversight by the National Assembly (South Korea).
Amendments after 2015 provoked debate among political parties such as the Democratic Party of Korea and the People Power Party (South Korea), and triggered litigation before the Constitutional Court of Korea concerning proportionality and rights adjudicated against standards referenced by international bodies like the United Nations Human Rights Council. Controversies have included disputes over digital contact tracing practices involving corporations subject to regulation by the Korea Communications Commission and privacy complaints filed with the Personal Information Protection Commission (South Korea), as well as policy critiques from public health scholars at Seoul National University and Yonsei University regarding transparency and administrative accountability reported in outlets such as The Korea Herald and Yonhap News Agency.